EV

Eminent Venture Capital

Asia, Fujian, China, Taipei

Description

Eminent Venture Capital is a private equity fund.

Investor Profile

Eminent Venture Capital has made 7 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series D (29%)
  • Private Equity (14%)
  • Series E (14%)
  • Series Unknown (14%)
  • Series C (14%)
  • Series B (14%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Biopharma
  • Pharmaceutical
  • Manufacturing
  • Medical Device
  • Therapeutics
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Eminent Venture Capital frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 2
RUSNANO
North America, California, United States, Menlo Park
Co-Investments: 2
BL
Asia, T'ai-pei, Taiwan, Taipei
Co-Investments: 2
I2BF Global Ventures
North America, New York, United States, New York
Co-Investments: 2
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 1
Advent International
North America, Massachusetts, United States, Boston
Co-Investments: 1
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 2
LI
North America, Massachusetts, United States, Chestnut Hill
Co-Investments: 2
+ND Capital
North America, California, United States, San Mateo
Co-Investments: 3
Flagship Pioneering
North America, Massachusetts, United States, Cambridge
Co-Investments: 3

Which angels does Eminent Venture Capital often collaborate with?

SH
North America, California, United States, Santa Monica
Shared Deals: 1

What are some of recent deals done by Eminent Venture Capital?

NeOnc Technologies

Woodland Hills, California, United States

NeOnc Technologies develops intranasal inhalation dosing therapies for the treatment of brain and lung cancers.

BiotechnologyHealth CareManufacturingMedical Device
Series UnknownFeb 8, 2023
Amount Raised: $10,000,000
Selecta Biosciences

Watertown, Massachusetts, United States

Selecta Biosciences is a clinical-stage biotechnology company with an unrelenting commitment to overcoming immunogenicity.

BiopharmaBiotechnologyPharmaceutical
Series ESep 8, 2015
Amount Raised: $38,000,000
Tarveda Therapeutics

Watertown, Massachusetts, United States

Tarveda Therapeutics is a developer of miniature drug conjugates designed for the treatment of patients with a wide range of solid tumors.

BiotechnologyHealth CareHealth DiagnosticsMedicalTherapeutics
Series BJan 7, 2015
Amount Raised: $21,000,000
Selecta Biosciences

Watertown, Massachusetts, United States

Selecta Biosciences is a clinical-stage biotechnology company with an unrelenting commitment to overcoming immunogenicity.

BiopharmaBiotechnologyPharmaceutical
Private EquityOct 15, 2014
Amount Raised: $20,000,000
Cardiva Medical

Sunnyvale, California, United States

Cardiva Medical is focused on developing and commercializing vascular closure technology to help the body heal.

Health CareManufacturingMedical Device
Series DMay 5, 2008
Amount Raised: $15,500,000
GlobeImmune

Louisville, Colorado, United States

GlobeImmune focused on developing products for the treatment of cancer and infectious diseases based on our proprietary Tarmogen® platform.

BiotechnologyMedicalTherapeutics
Series CSep 26, 2007
Amount Raised: $41,200,000
Nereus Pharmaceuticals

San Diego, California, United States

Nereus Pharmaceuticals engages in the discovery and development of therapeutics for the treatment of infectious diseases and inflammation.

BiotechnologyHealth CareMedical
Series DAug 9, 2007
Amount Raised: $45,000,000